Skip to main content
NCEL
NASDAQ Life Sciences

NewcelX Offloads Mazindol Portfolio for $500K Upfront, Up to $55M in Milestones

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.64
Mkt Cap
$14.213M
52W Low
$1.83
52W High
$6.48
52W Position info
44% above low
Off High info
59% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

NCEL sits 44% above its 52-week low of $1.83 on elevated volume (2.2× avg).

Summary

NewcelX signed a binding term sheet to sell its worldwide Mazindol portfolio, taking only $500K in attributed upfront value — just $30K of it cash, with the rest in shares equal to 9.4% of buyer REA's fully diluted equity after closing. The deal carries up to $55M in contingent milestones plus 2%-8% royalties on global net sales, so the real money depends on development and commercialization that may never happen. The cash component is negligible against a company that disclosed $710K in cash and a going concern warning in its September 6-K, so this does not solve the funding problem. It does strip out a legacy asset as management pivots to the cell-therapy pipeline, and the REA stake gives NewcelX a levered bet on the buyer's execution. Definitive documents and closing conditions still have to be satisfied before anything is final.

At the time of this announcement, NCEL was trading at $2.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.2M. The 52-week trading range was $1.83 to $6.48. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

NCEL - Latest Insights

NCEL
Nov 09, 2026, 9:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.34
Real-time Price: $2.46 info
Change: +$0.120 (+5%) info
Market Cap: $13.244M info
NCEL
Sep 18, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.15
Real-time Price: $2.46 info
Change: -$0.690 (-22%) info
Market Cap: $13.244M info
NCEL
Aug 03, 2026, 4:29 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.26
Real-time Price: $2.46 info
Change: -$0.7999 (-25%) info
Market Cap: $13.244M info
NCEL
Jul 31, 2026, 9:11 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.52
Real-time Price: $2.46 info
Change: -$1.06 (-30%) info
Market Cap: $13.244M info
NCEL
Jul 08, 2026, 9:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.91
Real-time Price: $2.46 info
Change: -$1.45 (-37%) info
Market Cap: $13.244M info